A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata (BRAVE-AA-PEDS)

The main purpose of the study is to assess efficacy and safety of Baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in children from 6 years to less than 18 years of age.

Enter your city or zip code to find the nearest site

See if You May Qualify

Answer a few questions to see if you meet key criteria for this study.

Trial Summary

Age Range
6 - 17 years
Conditions the trial is for
Alopecia Areata (hair loss)
What the trial is testing?
Could I receive a Placebo?
Enrollment Goal
Trial Dates
Feb 27, 2023 - Aug 2029
How long will I be in the trial?
The study will last approximately 2.5 years long and up to 18 visits.
Trial Phase

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Have severe areata alopecia (AA) for at least 1 year

  • Current AA episode of at least 6 months’ duration with hair loss encompassing ≥50% of the scalp

  • Current episode of severe to very severe alopecia areata of less than 8 years 

  • Participants who have severe AA for ≥8 years may be enrolled if episodes of regrowth, spontaneous or under treatment, have been observed on the affected areas over the past 8 years

Participants Must Not:

  • Participants must not have primarily “diffuse” type of alopecia areata

  • Participants must not be currently experiencing other forms of alopecia or any other health problem that would make it difficult to see how the study drug is working on alopecia areata

  • Participants must not have topical applied to scalp within 4 weeks of randomization

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Take the Next Step

Complete this Lilly Trial Connect questionnaire to find out if this clinical trial may be a good fit for you, or a loved one.
When you press Start Lilly Trial Connect, you will answer questions about relevant medical conditions and treatment history. The answers will be compared to some of the key criteria for this trial, called inclusion and exclusion criteria.

If your responses show that the trial may be a good fit, you can:
  • Select which clinical trial site works best for you.
  • Share your details and questionnaire directly with site(s) that allow this.
  • Get contact details for the site(s) of your choice.

Completing the Trial Connect questionnaire doesn’t mean that you will be enrolled in a study. There may be more eligibility criteria for the study which are assessed by the Lilly clinical team.

Clinical Trial Resources

Immunology  Research

Click the below button to learn more about our autoimmune disease research and clinical trials.

Learn More

Learn About Our Pediatric Research

With the help of research study participants, we are learning about pediatric conditions and potential new approaches to treating disease.

Learn More

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.